Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Intercept cuts targets for pivotal NASH study
Intercept cuts targets for pivotal NASH study
Intercept cuts targets for pivotal NASH study
Submitted by
admin
on February 14, 2017 - 9:37am
Source:
BioPharma Dive
News Tags:
Intercept Pharma
NASH
clinical trials
OCA
obeticholic acid
Headline:
Intercept cuts targets for pivotal NASH study
Do Not Allow Advertisers to Use My Personal information
